Data coverage, completeness and provenance for AROVELLA THERAPEUTICS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T03:05:18. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0530 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0510 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0510 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0500 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0490 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/ALA/prices · Price parameters and adjustment semantics
Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia.
Website: https://www.arovella.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/ALA/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 22 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 25 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 26 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 27 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 8 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/ALA
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/ALA/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/ALA/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/ALA/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/ALA/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/ALA
Free tier — instant API key. Built for AI agents.